Akilesh Bapu
Head of AI Product Development, Hightouch. On 1 show, 1 appearance. The Shows tab opens the full record on each.
founderexecutiveengineer@akileshbapu ↗LinkedIn ↗akile.sh ↗
Akilesh Bapu co-founded DeepScribe, an ambient AI medical scribe platform that generates structured EHR clinical notes to address physician burnout. He studied Electrical Engineering and Computer Sciences at UC Berkeley before leaving the master's program to lead the venture-backed company.
1shows
1appearances
16statements
2resolved
0supported
0contradicted
0%fully supported
Everything Akilesh Bapu said on any show that made the record, most notable first. Each card names its show and opens the statement there.
DeepScribe sees more impact fine-tuning in-house LLMs than GPT-4
“So with GPT-IV, to be honest, we haven't gotten the impact we'd like in terms of fine-tuning. Where we've seen the most impact is with our own in-house LLM.”
Bapu: Healthcare AI risks triggering another wave of clinician AI burnout
“It also runs the risk of that same burnout occurring again.”
Bapu: Healthcare AI lacks proven system-wide adoption despite strong sales
“People are definitely buying but what's not shown yet is whether these solutions can gain true system-wide adoption.”
DeepScribe CEO: AI achieved parity with human scribes, enabling full automation
“A couple months ago for the first time achieved parity with our AI and our expert human scribes, at which point we took them out of the loop. And so now DeepScribe is fully automated”
DeepScribe ended offshore reviewer contracts as clinicians stopped requesting human review
“Clinicians are barely sending the note to the human to review, yet we were keeping that option. We're keeping this like base level contract with our offshore suppliers. So we decided to officially make the move and that's when we started to see complete shift.”
DeepScribe discards LLM output if it lacks classical model validation
“So for a given task, we'll have a classical model typically produce that that same output. And then if the LLM puts in something that the classical model didn't have in its output we'll go ahead and only go with the classical model's output and disregard the L…”
Bapu: Apple Vision Pro adoption in health systems will probably never happen
“It depends on Apple's Vision Pro adoption across its customer base of health systems which probably will never happen, sadly.”
DeepScribe drafts off Nuance's enterprise market education to win health clients
“We really ride off the backs of Nuance, which is the 800 pound gorilla in our space that is trying to do something similar to what we're doing, but they have the distribution advantage. So they've gone and educated all the customers, and we follow on and basic…”
DeepScribe initially targeted private practices because large health systems ignored AI startups
“At DeepScribe, a lot of our initial journey was actually through private practices. So we sidestepped health systems because the sales process and the go-to-market Just wasn't there with these large, larger organizations because they didn't take us and other h…”
Removing humans from the loop requires designing products without safety nets
“In order to get the human on loop, we had to be intentional about it. We had to start building around the fact that a human won't be there anymore.”
DeepScribe has gathered over 2.5 million labeled medical conversations
“And we have a little over two and a half million conversations right now. They're all labeled.”
Bapu: Only 50% of oncologist documentation comes from direct conversations
“But if you look at oncologist, about 50% of their information comes from the conversation. About one fourth comes from a summary that they would have done, and then another fourth may come from previous visits.”
DeepScribe grew from zero to $6M ARR purely through inbound marketing
“We bought AdWords on Facebook and Google and all of our traffic and all of our initial sales from I think zero to six million in ARR came from inbound.”
DeepScribe achieves nearly 100% patient consent rate
“Through that, we've been able to get basically a hundred percent consent from patients”
Bapu: 30% of CMIOs are evaluating and purchasing generative AI
“Now there's a stat floating around that 30% of CMIOs, which is for us, our customer are now looking at generative AI solutions and looking to purchase generative AI solutions.”
One line per show, most statements first. The link opens Akilesh's full record on that show: the calibration, argument clarity, speaking style and every statement made there.
| Show | Role there | Eps | Statements | Record | |
|---|---|---|---|---|---|
 MADLEDGER | Head of AI Product Development, Hightouch | 1 | 16 | 0% 0/2 | full record on the MAD Podcast → |